New Biomarkers, New Targets in Advanced NSCLC

Perry Elliott, MD, FRCP - What’s New and What’s Next? Expanding Our Understanding of HCM in 2023

Perry Elliott, MD, FRCP - What’s New and What’s Next? Expanding Our Understanding of HCM in 2023...

2 years ago

24:45

Edward B. Garon, MD, MS - Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet Needs in NSCLC Without Actionable Mutations

Edward B. Garon, MD, MS - Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet Needs in NSCLC Without Actionable Mutations...

2 years ago

20:33

Rosalyn Juergens, MD, PhD - Why Precision Matters in NSCLC: Challenges and Solutions for Targeting Rare Oncogenic Driver Mutations in the Canadian Landscape

Rosalyn Juergens, MD, PhD - Why Precision Matters in NSCLC: Challenges and Solutions for Targeting Rare Oncogenic Driver Mutations in the Canadian Landscape...

2 years ago

15:18

Claus Vogelmeier, MD - Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD

Claus Vogelmeier, MD - Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD...

2 years ago

20:39

Perry Elliott, MD, FRCP - Continuing Our Conversation in HCM: Compelling Questions and Evolving Considerations

Perry Elliott, MD, FRCP - Continuing Our Conversation in HCM: Compelling Questions and Evolving Considerations...

2 years ago

12:54

Walter Chow, BScPhm, MD - Better Outcomes for Your Patients Living With Obesity: Practical Management Strategies for Primary Care

Walter Chow, BScPhm, MD - Better Outcomes for Your Patients Living With Obesity: Practical Management Strategies for Primary Care...

2 years ago

59:12

Laura Obici, MD - Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (ATTR): Shared Perspectives From Patients and Providers

Laura Obici, MD - Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (ATTR): Shared Perspectives From Patients and Providers...

2 years ago

38:11

Peter J. Lin, MD, CCFP - Severe Uncontrolled Versus Difficult-to-Treat Asthma: Strategies for Detection, Differentiation, and Referral

Peter J. Lin, MD, CCFP - Severe Uncontrolled Versus Difficult-to-Treat Asthma: Strategies for Detection, Differentiation, and Referral...

2 years ago

09:29

Wong Seng Weng, MBBS, MRCP, FAMS - Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now and What Next?

Wong Seng Weng, MBBS, MRCP, FAMS - Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now and What Next?...

2 years ago

54:50

New Biomarkers, New Targets in Advanced NSCLC

PeerVoice Heart & Lung Video